nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRR3—peripheral nervous system—Parkinson's disease	0.0234	0.0522	CbGeAlD
Adinazolam—GABRR2—peripheral nervous system—Parkinson's disease	0.0203	0.0453	CbGeAlD
Adinazolam—GABRR1—peripheral nervous system—Parkinson's disease	0.0196	0.0436	CbGeAlD
Adinazolam—GABRR3—nerve—Parkinson's disease	0.0183	0.0407	CbGeAlD
Adinazolam—GABRR2—nerve—Parkinson's disease	0.0158	0.0353	CbGeAlD
Adinazolam—GABRR1—nerve—Parkinson's disease	0.0153	0.034	CbGeAlD
Adinazolam—GABRA6—hindbrain—Parkinson's disease	0.0095	0.0212	CbGeAlD
Adinazolam—GABRB2—hindbrain—Parkinson's disease	0.00699	0.0156	CbGeAlD
Adinazolam—GABRA2—hindbrain—Parkinson's disease	0.00639	0.0142	CbGeAlD
Adinazolam—GABRR1—forebrain—Parkinson's disease	0.00632	0.0141	CbGeAlD
Adinazolam—GABRA1—hindbrain—Parkinson's disease	0.00618	0.0138	CbGeAlD
Adinazolam—GABRD—forebrain—Parkinson's disease	0.00549	0.0122	CbGeAlD
Adinazolam—GABRA6—brainstem—Parkinson's disease	0.00545	0.0121	CbGeAlD
Adinazolam—GABRG1—forebrain—Parkinson's disease	0.00529	0.0118	CbGeAlD
Adinazolam—GABRA5—forebrain—Parkinson's disease	0.0051	0.0114	CbGeAlD
Adinazolam—GABRA4—forebrain—Parkinson's disease	0.00463	0.0103	CbGeAlD
Adinazolam—GABRR3—head—Parkinson's disease	0.00434	0.00966	CbGeAlD
Adinazolam—GABRR3—nervous system—Parkinson's disease	0.00411	0.00915	CbGeAlD
Adinazolam—GABRB2—brainstem—Parkinson's disease	0.00401	0.00893	CbGeAlD
Adinazolam—GABRD—medulla oblongata—Parkinson's disease	0.00397	0.00884	CbGeAlD
Adinazolam—GABRG2—forebrain—Parkinson's disease	0.00387	0.00862	CbGeAlD
Adinazolam—GABRB2—forebrain—Parkinson's disease	0.00387	0.00862	CbGeAlD
Adinazolam—GABRG1—medulla oblongata—Parkinson's disease	0.00382	0.00851	CbGeAlD
Adinazolam—GABRG3—head—Parkinson's disease	0.0038	0.00846	CbGeAlD
Adinazolam—GABRR2—head—Parkinson's disease	0.00376	0.00837	CbGeAlD
Adinazolam—GABRB1—medulla oblongata—Parkinson's disease	0.0037	0.00825	CbGeAlD
Adinazolam—GABRA2—brainstem—Parkinson's disease	0.00366	0.00816	CbGeAlD
Adinazolam—GABRD—midbrain—Parkinson's disease	0.00363	0.00808	CbGeAlD
Adinazolam—GABRR1—head—Parkinson's disease	0.00362	0.00806	CbGeAlD
Adinazolam—GABRG3—nervous system—Parkinson's disease	0.0036	0.00802	CbGeAlD
Adinazolam—GABRR2—nervous system—Parkinson's disease	0.00356	0.00794	CbGeAlD
Adinazolam—GABRA1—brainstem—Parkinson's disease	0.00354	0.00788	CbGeAlD
Adinazolam—GABRA2—forebrain—Parkinson's disease	0.00354	0.00787	CbGeAlD
Adinazolam—GABRG1—midbrain—Parkinson's disease	0.00349	0.00777	CbGeAlD
Adinazolam—GABRG3—central nervous system—Parkinson's disease	0.00347	0.00772	CbGeAlD
Adinazolam—GABRR1—nervous system—Parkinson's disease	0.00343	0.00764	CbGeAlD
Adinazolam—GABRA1—forebrain—Parkinson's disease	0.00342	0.00761	CbGeAlD
Adinazolam—GABRG1—spinal cord—Parkinson's disease	0.00341	0.00759	CbGeAlD
Adinazolam—GABRB1—midbrain—Parkinson's disease	0.00338	0.00754	CbGeAlD
Adinazolam—GABRR2—cerebellum—Parkinson's disease	0.00335	0.00747	CbGeAlD
Adinazolam—GABRR1—central nervous system—Parkinson's disease	0.0033	0.00736	CbGeAlD
Adinazolam—GABRB1—spinal cord—Parkinson's disease	0.0033	0.00736	CbGeAlD
Adinazolam—GABRD—head—Parkinson's disease	0.00314	0.007	CbGeAlD
Adinazolam—GABRG1—head—Parkinson's disease	0.00303	0.00674	CbGeAlD
Adinazolam—GABRA6—head—Parkinson's disease	0.00301	0.0067	CbGeAlD
Adinazolam—GABRD—nervous system—Parkinson's disease	0.00298	0.00664	CbGeAlD
Adinazolam—GABRB3—forebrain—Parkinson's disease	0.00297	0.00662	CbGeAlD
Adinazolam—GABRB1—head—Parkinson's disease	0.00294	0.00654	CbGeAlD
Adinazolam—GABRA5—head—Parkinson's disease	0.00292	0.0065	CbGeAlD
Adinazolam—GABRD—central nervous system—Parkinson's disease	0.00287	0.00639	CbGeAlD
Adinazolam—GABRG1—nervous system—Parkinson's disease	0.00287	0.00639	CbGeAlD
Adinazolam—GABRA6—nervous system—Parkinson's disease	0.00285	0.00635	CbGeAlD
Adinazolam—GABRD—cerebellum—Parkinson's disease	0.00281	0.00625	CbGeAlD
Adinazolam—GABRB2—medulla oblongata—Parkinson's disease	0.0028	0.00623	CbGeAlD
Adinazolam—GABRG2—medulla oblongata—Parkinson's disease	0.0028	0.00623	CbGeAlD
Adinazolam—GABRB1—nervous system—Parkinson's disease	0.00278	0.0062	CbGeAlD
Adinazolam—GABRA5—nervous system—Parkinson's disease	0.00277	0.00616	CbGeAlD
Adinazolam—GABRG1—central nervous system—Parkinson's disease	0.00276	0.00615	CbGeAlD
Adinazolam—GABRG3—brain—Parkinson's disease	0.00275	0.00613	CbGeAlD
Adinazolam—GABRA6—central nervous system—Parkinson's disease	0.00275	0.00612	CbGeAlD
Adinazolam—GABRA3—head—Parkinson's disease	0.00272	0.00605	CbGeAlD
Adinazolam—GABRG1—cerebellum—Parkinson's disease	0.0027	0.00601	CbGeAlD
Adinazolam—GABRA6—cerebellum—Parkinson's disease	0.00268	0.00598	CbGeAlD
Adinazolam—GABRB1—central nervous system—Parkinson's disease	0.00268	0.00597	CbGeAlD
Adinazolam—GABRA5—central nervous system—Parkinson's disease	0.00266	0.00594	CbGeAlD
Adinazolam—GABRA4—head—Parkinson's disease	0.00265	0.0059	CbGeAlD
Adinazolam—GABRP—head—Parkinson's disease	0.00263	0.00586	CbGeAlD
Adinazolam—GABRR1—brain—Parkinson's disease	0.00262	0.00584	CbGeAlD
Adinazolam—GABRB1—cerebellum—Parkinson's disease	0.00262	0.00583	CbGeAlD
Adinazolam—GABRA3—nervous system—Parkinson's disease	0.00258	0.00574	CbGeAlD
Adinazolam—GABRB2—midbrain—Parkinson's disease	0.00256	0.00569	CbGeAlD
Adinazolam—GABRG2—midbrain—Parkinson's disease	0.00256	0.00569	CbGeAlD
Adinazolam—GABRA4—nervous system—Parkinson's disease	0.00251	0.00559	CbGeAlD
Adinazolam—GABRG2—spinal cord—Parkinson's disease	0.00249	0.00555	CbGeAlD
Adinazolam—GABRB2—spinal cord—Parkinson's disease	0.00249	0.00555	CbGeAlD
Adinazolam—GABRA3—central nervous system—Parkinson's disease	0.00248	0.00553	CbGeAlD
Adinazolam—GABRA1—medulla oblongata—Parkinson's disease	0.00247	0.0055	CbGeAlD
Adinazolam—GABRA4—central nervous system—Parkinson's disease	0.00242	0.00538	CbGeAlD
Adinazolam—GABRA4—cerebellum—Parkinson's disease	0.00236	0.00526	CbGeAlD
Adinazolam—GABRD—brain—Parkinson's disease	0.00228	0.00508	CbGeAlD
Adinazolam—GABRA1—midbrain—Parkinson's disease	0.00226	0.00502	CbGeAlD
Adinazolam—GABRB2—head—Parkinson's disease	0.00222	0.00493	CbGeAlD
Adinazolam—GABRG2—head—Parkinson's disease	0.00222	0.00493	CbGeAlD
Adinazolam—GABRA1—spinal cord—Parkinson's disease	0.0022	0.0049	CbGeAlD
Adinazolam—GABRG1—brain—Parkinson's disease	0.00219	0.00489	CbGeAlD
Adinazolam—GABRA6—brain—Parkinson's disease	0.00218	0.00486	CbGeAlD
Adinazolam—GABRB3—medulla oblongata—Parkinson's disease	0.00215	0.00478	CbGeAlD
Adinazolam—GABRB1—brain—Parkinson's disease	0.00213	0.00474	CbGeAlD
Adinazolam—GABRA5—brain—Parkinson's disease	0.00212	0.00471	CbGeAlD
Adinazolam—GABRB2—nervous system—Parkinson's disease	0.0021	0.00468	CbGeAlD
Adinazolam—GABRG2—nervous system—Parkinson's disease	0.0021	0.00468	CbGeAlD
Adinazolam—GABRA2—head—Parkinson's disease	0.00202	0.00451	CbGeAlD
Adinazolam—GABRG2—central nervous system—Parkinson's disease	0.00202	0.0045	CbGeAlD
Adinazolam—GABRB2—central nervous system—Parkinson's disease	0.00202	0.0045	CbGeAlD
Adinazolam—GABRE—head—Parkinson's disease	0.00201	0.00447	CbGeAlD
Adinazolam—GABRB2—cerebellum—Parkinson's disease	0.00198	0.0044	CbGeAlD
Adinazolam—GABRG2—cerebellum—Parkinson's disease	0.00198	0.0044	CbGeAlD
Adinazolam—GABRA3—brain—Parkinson's disease	0.00197	0.00439	CbGeAlD
Adinazolam—GABRB3—midbrain—Parkinson's disease	0.00196	0.00437	CbGeAlD
Adinazolam—GABRA1—head—Parkinson's disease	0.00196	0.00436	CbGeAlD
Adinazolam—GABRA4—brain—Parkinson's disease	0.00192	0.00427	CbGeAlD
Adinazolam—GABRA2—nervous system—Parkinson's disease	0.00192	0.00427	CbGeAlD
Adinazolam—GABRB3—spinal cord—Parkinson's disease	0.00191	0.00426	CbGeAlD
Adinazolam—GABRE—nervous system—Parkinson's disease	0.0019	0.00424	CbGeAlD
Adinazolam—GABRA1—nervous system—Parkinson's disease	0.00185	0.00413	CbGeAlD
Adinazolam—GABRA2—central nervous system—Parkinson's disease	0.00185	0.00411	CbGeAlD
Adinazolam—GABRE—central nervous system—Parkinson's disease	0.00183	0.00408	CbGeAlD
Adinazolam—GABRA2—cerebellum—Parkinson's disease	0.00181	0.00402	CbGeAlD
Adinazolam—GABRA1—central nervous system—Parkinson's disease	0.00179	0.00398	CbGeAlD
Adinazolam—GABRA1—cerebellum—Parkinson's disease	0.00175	0.00389	CbGeAlD
Adinazolam—GABRB3—head—Parkinson's disease	0.0017	0.00379	CbGeAlD
Adinazolam—GABRB3—nervous system—Parkinson's disease	0.00161	0.00359	CbGeAlD
Adinazolam—GABRB2—brain—Parkinson's disease	0.00161	0.00358	CbGeAlD
Adinazolam—GABRG2—brain—Parkinson's disease	0.00161	0.00358	CbGeAlD
Adinazolam—Clomipramine—GSTP1—Parkinson's disease	0.00159	0.0767	CrCbGaD
Adinazolam—GABRB3—central nervous system—Parkinson's disease	0.00155	0.00346	CbGeAlD
Adinazolam—GABRB3—cerebellum—Parkinson's disease	0.00152	0.00338	CbGeAlD
Adinazolam—GABRA2—brain—Parkinson's disease	0.00147	0.00327	CbGeAlD
Adinazolam—GABRE—brain—Parkinson's disease	0.00145	0.00324	CbGeAlD
Adinazolam—GABRA1—brain—Parkinson's disease	0.00142	0.00316	CbGeAlD
Adinazolam—GABRB3—brain—Parkinson's disease	0.00123	0.00275	CbGeAlD
Adinazolam—Chlorprothixene—DRD3—Parkinson's disease	0.00122	0.0588	CrCbGaD
Adinazolam—Chlorprothixene—DRD1—Parkinson's disease	0.0012	0.0577	CrCbGaD
Adinazolam—Flunitrazepam—CYP2E1—Parkinson's disease	0.000944	0.0456	CrCbGaD
Adinazolam—Chlordiazepoxide—CYP2D6—Parkinson's disease	0.000894	0.0431	CrCbGaD
Adinazolam—Chlorpromazine—HTR7—Parkinson's disease	0.000893	0.0431	CrCbGaD
Adinazolam—Nitrazepam—CYP2E1—Parkinson's disease	0.000852	0.0411	CrCbGaD
Adinazolam—Chlorprothixene—DRD2—Parkinson's disease	0.000843	0.0407	CrCbGaD
Adinazolam—Chlorpromazine—DRD3—Parkinson's disease	0.000839	0.0405	CrCbGaD
Adinazolam—CYP3A4—nervous system—Parkinson's disease	0.000826	0.00184	CbGeAlD
Adinazolam—Chlorpromazine—DRD1—Parkinson's disease	0.000824	0.0398	CrCbGaD
Adinazolam—CYP3A4—central nervous system—Parkinson's disease	0.000795	0.00177	CbGeAlD
Adinazolam—Ketazolam—ABCB1—Parkinson's disease	0.000765	0.0369	CrCbGaD
Adinazolam—Flurazepam—CYP2E1—Parkinson's disease	0.000758	0.0366	CrCbGaD
Adinazolam—Midazolam—CYP2E1—Parkinson's disease	0.000702	0.0339	CrCbGaD
Adinazolam—Chlorpromazine—HTR1A—Parkinson's disease	0.000684	0.033	CrCbGaD
Adinazolam—Clomipramine—HTR2A—Parkinson's disease	0.000654	0.0316	CrCbGaD
Adinazolam—Chlorprothixene—HTR2A—Parkinson's disease	0.000651	0.0314	CrCbGaD
Adinazolam—Diazepam—CYP2E1—Parkinson's disease	0.000602	0.0291	CrCbGaD
Adinazolam—Clomipramine—CYP2D6—Parkinson's disease	0.000598	0.0289	CrCbGaD
Adinazolam—Chlorpromazine—DRD2—Parkinson's disease	0.000581	0.028	CrCbGaD
Adinazolam—Chlorpromazine—CYP2E1—Parkinson's disease	0.000559	0.027	CrCbGaD
Adinazolam—Clobazam—ABCB1—Parkinson's disease	0.000541	0.0261	CrCbGaD
Adinazolam—Chlorpromazine—HTR2A—Parkinson's disease	0.000449	0.0217	CrCbGaD
Adinazolam—Nitrazepam—ABCB1—Parkinson's disease	0.000447	0.0216	CrCbGaD
Adinazolam—Clomipramine—ABCB1—Parkinson's disease	0.000427	0.0206	CrCbGaD
Adinazolam—Chlorprothixene—ABCB1—Parkinson's disease	0.000425	0.0205	CrCbGaD
Adinazolam—Chlorpromazine—CYP2D6—Parkinson's disease	0.00041	0.0198	CrCbGaD
Adinazolam—Flurazepam—ABCB1—Parkinson's disease	0.000397	0.0192	CrCbGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000384	0.000725	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—HSPA8—Parkinson's disease	0.000383	0.000722	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000383	0.000722	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000382	0.000721	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000382	0.00072	CbGpPWpGaD
Adinazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00038	0.000716	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000377	0.000712	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000377	0.000712	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—HSPA8—Parkinson's disease	0.000376	0.000709	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000375	0.000707	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000372	0.000701	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000371	0.000699	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—DLG4—Parkinson's disease	0.00037	0.000698	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—HSPA8—Parkinson's disease	0.00037	0.000697	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00037	0.000697	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000368	0.000695	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000368	0.000695	CbGpPWpGaD
Adinazolam—Midazolam—ABCB1—Parkinson's disease	0.000368	0.0178	CrCbGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000368	0.000694	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—HSPA8—Parkinson's disease	0.000367	0.000693	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000366	0.00069	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.000365	0.000689	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000362	0.000682	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	0.000362	0.000682	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000361	0.00068	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00036	0.000679	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—COMT—Parkinson's disease	0.00036	0.000679	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—DLG4—Parkinson's disease	0.000359	0.000678	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000359	0.000677	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—MAOA—Parkinson's disease	0.000358	0.000674	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	0.000356	0.000672	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—COMT—Parkinson's disease	0.000355	0.000669	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.000353	0.000666	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—MAOA—Parkinson's disease	0.000352	0.000664	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	0.000351	0.000663	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000347	0.000655	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000347	0.000654	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	0.000346	0.000653	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000345	0.000651	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000345	0.00065	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000344	0.000648	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000343	0.000646	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000342	0.000645	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.00034	0.000641	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000339	0.000639	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000338	0.000638	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000338	0.000637	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000337	0.000635	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—COMT—Parkinson's disease	0.000336	0.000633	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000334	0.00063	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000333	0.000629	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—MAOA—Parkinson's disease	0.000333	0.000628	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000332	0.000626	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—COMT—Parkinson's disease	0.000331	0.000625	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000331	0.000624	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—MAOA—Parkinson's disease	0.000329	0.00062	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000328	0.000619	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000326	0.000615	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000325	0.000614	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000324	0.00061	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00032	0.000603	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00032	0.000603	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000316	0.000596	CbGpPWpGaD
Adinazolam—Diazepam—ABCB1—Parkinson's disease	0.000316	0.0152	CrCbGaD
Adinazolam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000315	0.000594	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000315	0.000594	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000314	0.000592	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000312	0.000589	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000309	0.000583	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000305	0.000575	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000303	0.000571	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000301	0.000567	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000298	0.000562	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000296	0.000558	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000294	0.000555	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000294	0.000555	CbGpPWpGaD
Adinazolam—Chlorpromazine—ABCB1—Parkinson's disease	0.000293	0.0141	CrCbGaD
Adinazolam—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000292	0.000551	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000292	0.000551	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00029	0.000546	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000289	0.000545	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000289	0.000545	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000287	0.000541	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000285	0.000537	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000284	0.000536	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000284	0.000535	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000282	0.000532	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000282	0.000532	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.00028	0.000529	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000279	0.000526	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000278	0.000525	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000277	0.000523	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000276	0.000521	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000275	0.000519	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000274	0.000517	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000274	0.000516	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000272	0.000513	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000269	0.000507	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000267	0.000504	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000265	0.000501	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000261	0.000493	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000257	0.000484	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000252	0.000475	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00025	0.000472	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00025	0.000472	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000246	0.000464	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000242	0.000457	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000242	0.000456	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000242	0.000456	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000241	0.000454	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000239	0.00045	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000234	0.000441	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000232	0.000438	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000231	0.000435	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000229	0.000432	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000228	0.000429	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000224	0.000423	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000221	0.000418	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000221	0.000417	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00022	0.000414	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000219	0.000412	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000218	0.000411	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000217	0.000408	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000215	0.000406	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000215	0.000405	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000212	0.0004	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000211	0.000397	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00021	0.000395	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000206	0.000389	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000204	0.000384	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000202	0.000382	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000201	0.000379	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000196	0.000369	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000192	0.000361	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00019	0.000358	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000187	0.000353	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000186	0.000351	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000185	0.000349	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000185	0.000348	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000184	0.000347	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000183	0.000346	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000183	0.000345	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000182	0.000344	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000182	0.000344	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000182	0.000343	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000181	0.000341	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00018	0.000339	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00018	0.000339	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00018	0.000339	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000179	0.000337	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000178	0.000337	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000177	0.000334	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000176	0.000331	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000175	0.000331	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000175	0.00033	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000172	0.000325	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000171	0.000323	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00017	0.000321	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000168	0.000317	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000168	0.000317	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000168	0.000316	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000165	0.000312	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00016	0.000302	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000155	0.000293	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000154	0.000289	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000153	0.000289	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000153	0.000288	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00015	0.000283	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000149	0.000281	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000149	0.000281	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000147	0.000277	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000146	0.000276	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000146	0.000276	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000145	0.000274	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000144	0.000271	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000143	0.000271	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000143	0.00027	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00014	0.000265	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000134	0.000253	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000133	0.000251	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000131	0.000247	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000128	0.000241	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000126	0.000238	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000123	0.000231	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000119	0.000224	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000119	0.000224	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000112	0.000211	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000112	0.000211	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00011	0.000208	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.00011	0.000207	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.000206	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000109	0.000205	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000108	0.000204	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000108	0.000204	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000106	0.0002	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000101	0.000191	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000101	0.00019	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	9.94e-05	0.000188	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	9.12e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GBA—Parkinson's disease	9.01e-05	0.00017	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—DBH—Parkinson's disease	9.01e-05	0.00017	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—FBP1—Parkinson's disease	9.01e-05	0.00017	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	7.15e-05	0.000135	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ND3—Parkinson's disease	7.15e-05	0.000135	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	6.72e-05	0.000127	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—OMD—Parkinson's disease	6.72e-05	0.000127	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—DDC—Parkinson's disease	6.61e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	6.37e-05	0.00012	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTA4—Parkinson's disease	6.25e-05	0.000118	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.17e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GCH1—Parkinson's disease	6.08e-05	0.000115	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	5.62e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MAOB—Parkinson's disease	5.57e-05	0.000105	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—FBP1—Parkinson's disease	5.42e-05	0.000102	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GBA—Parkinson's disease	5.42e-05	0.000102	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—DBH—Parkinson's disease	5.42e-05	0.000102	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.3e-05	9.99e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	4.14e-05	7.8e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CTGF—Parkinson's disease	4.06e-05	7.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—DDC—Parkinson's disease	3.98e-05	7.5e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	3.78e-05	7.14e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.76e-05	7.08e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NQO1—Parkinson's disease	3.74e-05	7.06e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TH—Parkinson's disease	3.69e-05	6.95e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYCS—Parkinson's disease	3.54e-05	6.68e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.38e-05	6.38e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.35e-05	6.31e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—COMT—Parkinson's disease	3.14e-05	5.91e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.12e-05	5.88e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.11e-05	5.87e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.08e-05	5.8e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.95e-05	5.57e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.87e-05	5.41e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.75e-05	5.18e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MTHFR—Parkinson's disease	2.53e-05	4.78e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.49e-05	4.69e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.44e-05	4.6e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—APOE—Parkinson's disease	2.36e-05	4.45e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.28e-05	4.29e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.25e-05	4.24e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TH—Parkinson's disease	2.22e-05	4.18e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.13e-05	4.01e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—INS—Parkinson's disease	2.02e-05	3.8e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—COMT—Parkinson's disease	1.89e-05	3.56e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.88e-05	3.54e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.87e-05	3.53e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.85e-05	3.49e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.78e-05	3.35e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.72e-05	3.25e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.65e-05	3.11e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.52e-05	2.87e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—APOE—Parkinson's disease	1.42e-05	2.68e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—INS—Parkinson's disease	1.21e-05	2.29e-05	CbGpPWpGaD
